Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy.

ABSTRACT:

SUBMITTER: Aleman A 

PROVIDER: S-EPMC12370277 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature